A Randomized, Double-Blind, Phase II Study of Ramucirumab Plus Docetaxel vs Placebo Plus Docetaxel in Japanese Patients With Stage IV Non-Small Cell Lung Cancer After Disease Progression on Platinum-Based Therapy
Lung Cancer - Netherlands
doi 10.1016/j.lungcan.2016.07.019
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2016
Authors
Publisher
Elsevier BV